2008
DOI: 10.1590/s0100-879x2008000200002
|View full text |Cite
|
Sign up to set email alerts
|

Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS)

Abstract: Apolipoprotein E (ApoE) polymorphism influences lipid metabolism, but its association with arterial hypertension is controversial. The objective of this study was to examine the association between ApoE polymorphism and prevalent hypertension in a large unselected population of older adults. Participants from the baseline of the Bambuí Health Aging Study whose ApoE genes had been genotyped were selected for this study (N = 1406, aged 60-95 years). These subjects represented 80.7% of the total elderly residents… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
15
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(20 citation statements)
references
References 30 publications
(37 reference statements)
4
15
1
Order By: Relevance
“…The combination of a relatively mild elevation in physiological indicators of vascular risk with a genetic risk factor is associated with poorer state of brain and cognition than would be expected. The observed synergy between genetic and physiological risks in explaining cognitive deficits is in accord with previous reports regarding APOE ε4 (De Frias et al, 2007; Elias et al, 2008; Fuzikawa, Peixoto, Taufer, Moriguchi, & Lima-Costa, 2008; Peila et al, 2001) and the met allele of BDNF val66met polymorphism (Raz et al, 2008). Thus, this finding is in accord with the growing evidence that “normal” should be viewed in the context of individual’s genetic predisposition (Raz, 2011).…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…The combination of a relatively mild elevation in physiological indicators of vascular risk with a genetic risk factor is associated with poorer state of brain and cognition than would be expected. The observed synergy between genetic and physiological risks in explaining cognitive deficits is in accord with previous reports regarding APOE ε4 (De Frias et al, 2007; Elias et al, 2008; Fuzikawa, Peixoto, Taufer, Moriguchi, & Lima-Costa, 2008; Peila et al, 2001) and the met allele of BDNF val66met polymorphism (Raz et al, 2008). Thus, this finding is in accord with the growing evidence that “normal” should be viewed in the context of individual’s genetic predisposition (Raz, 2011).…”
Section: Discussionsupporting
confidence: 91%
“…In the present study, we did not evaluate many markers of vascular risk previously shown to interact with APOE genotype in vascular risk and correlate with cognitive performance decrements, such as homocysteine (Elias et al, 2008), triglycerides (De Frias et al, 2007), or LDL cholesterol (Fuzikawa et al, 2008). In addition, according to some studies, APOE ε4 may be associated with increased hippocampal atrophy in older women, but not men (Cohen, Small, Lalonde, Friz, & Sunderland, 2001).…”
Section: Discussionmentioning
confidence: 97%
“…The present study failed to demonstrate an association between APOE polymorphisms with blood pressure phenotypes and arterial stiffness. Corroborating some results of this study, Fuzikawa et al[49]studied 1406 Brazilian elderly individuals and found no association between APOE genotype and hypertension. Similarly, Carmo-Martins et al[50] studied 672 Portuguese subjects and failed to demonstrated an association with blood pressure.…”
Section: Discussionsupporting
confidence: 81%
“…Some of these papers contained information about populations of non-distinct racial descent and thus they were considered as mixed populations. [19][20][21][22] Two initially identified studies were excluded, as they contained overlapping subsets of individuals with other studies already included. 22,23 Several studies were discarded because they did not report data that could be used in the analysis (that is, the genotypes, the E4 carriers or the E4 allele frequencies for the contrasts between cases and controls) or they did not report data for the control group.…”
Section: Resultsmentioning
confidence: 99%